These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2478705)

  • 41. Value of maternal serum alpha-fetoprotein levels of 5.0 MOM or greater and prenatal sonography in predicting fetal outcome.
    Larson JM; Pretorius DH; Budorick NE; Scioscia AL
    Radiology; 1993 Oct; 189(1):77-81. PubMed ID: 7690492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound.
    Dashe JS; Twickler DM; Santos-Ramos R; McIntire DD; Ramus RM
    Am J Obstet Gynecol; 2006 Dec; 195(6):1623-8. PubMed ID: 16769022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
    Milunsky A; Alpert E; Neff RK; Frigoletto FD
    Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Informative value of varying serum alpha fetoprotein levels in pregnant women based on a screening program in a Hungarian institute. What next?].
    Wilhelm O; Lomniczi A; Dudar E; Szöke K; Máj C; Horváth E
    Orv Hetil; 1992 Dec; 133(51):3243-6. PubMed ID: 1282233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center.
    Cariati E; Brizzi L; Periti E
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):72-6. PubMed ID: 2480428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
    Sancken U; Bartels I
    Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Proposed normal values for alpha fetoprotein in maternal serum for the detection of neural tube closure defects and Down syndrome. Preliminary study].
    Carreras de Paz JJ; Silva Mendoza JM; Violante Diaz M; Cerrillo Hinojosa M; Ahued Ahued JR
    Ginecol Obstet Mex; 1991 Aug; 59():261-4. PubMed ID: 1722478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The HELLP syndrome: its association with unexplained elevation of MSAFP and MShCG in the second trimester.
    Morssink LP; Heringa MP; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1997 Jul; 17(7):601-6. PubMed ID: 9249859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maternal serum alphafetoprotein screening. University Medical Center.
    Morris N; Riconda D; Marfatia L; Ostrer H
    J Fla Med Assoc; 1991 Jun; 78(6):365-8. PubMed ID: 1714937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prenatal diagnosis of neural tube defects.
    Dembert ML; Harisiades JP
    Am Fam Physician; 1983 Feb; 27(2):241-4. PubMed ID: 6187201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.
    Milunsky A; Alpert E; Kitzmiller JL; Younger MD; Neff RK
    Am J Obstet Gynecol; 1982 Apr; 142(8):1030-2. PubMed ID: 6176126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Periodic health examination, 1994 update: 3. Primary and secondary prevention of neural tube defects. Canadian Task Force on the Periodic Health Examination.
    CMAJ; 1994 Jul; 151(2):159-66. PubMed ID: 7518734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ultrasound-adjusted risk and spectrum of fetal chromosomal abnormality in women with elevated maternal serum alpha-fetoprotein.
    Megerian G; Godmilow L; Donnenfeld AE
    Obstet Gynecol; 1995 Jun; 85(6):952-6. PubMed ID: 7539525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pregnancy outcomes after increasing maternal serum alpha-fetoprotein levels.
    Robinson L; Grau P; Crandall BF
    Obstet Gynecol; 1989 Jul; 74(1):17-20. PubMed ID: 2471946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Maternal serum alpha-fetoprotein and fetal triploidy.
    Pircon RA; Towers CV; Porto M; Gocke SE; Garite TJ
    Prenat Diagn; 1989 Oct; 9(10):701-7. PubMed ID: 2480590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Maternal serum alpha-fetoprotein screening programs and quality control for laboratories performing maternal serum and amniotic fluid alpha-fetoprotein assays: policy statement. American Society of Human Genetics.
    CMAJ; 1987 Jun; 136(12):1253-6. PubMed ID: 2438025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prenatal serum alpha-fetoprotein screening for neural tube defects.
    Macri JN; Weiss RR
    Obstet Gynecol; 1982 May; 59(5):633-9. PubMed ID: 6175932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol.
    Santolaya-Forgas J; Jessup J; Burd LI; Prins GS; Burton BK
    J Reprod Med; 1996 Feb; 41(2):87-90. PubMed ID: 8656420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MULTISCAN--a Scandinavian multicenter second trimester obstetric ultrasound and serum screening study.
    Jørgensen FS; Valentin L; Salvesen KA; Jørgensen C; Jensen FR; Bang J; Eik-Nes SH; Madsen M; Marsal K; Persson PH; Philip J; Bogstad JW; Nørgaard-Pedersen B
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):501-10. PubMed ID: 10376859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.